Category

Clinical Trials

Ultimovacs lab

Ultimovacs completes patient recruitment in Phase II trial

January 23, 2023

Ultimovacs has announced the completed …

Richard Godfrey

IRLAB announces Phase IIb results

January 18, 2023

IRLAB Therapeutics has announced the …

Ultimovacs lab

Cemiplimab to replace pembrolizumab in Ultimovacs trial

December 20, 2022

Ultimovacs has announced that cemiplimab …

Erik Manting

Mendus reports positive trial results

December 14, 2022

Mendus has presented survival data …

IRLAB reports Last Patient Last Visit in Phase IIb trial

December 14, 2022

IRLAB Therapeutics has announced that …

spago nanomedical

Spago Nanomedical initiates clinical trial in endometriosis

December 5, 2022

Spago Nanomedical has received regulatory …

Per Norlen Photo Jenny Leyman

Evaxion announces Phase 1/2a results

November 18, 2022

Evaxion Biotech has announced clinical …

EpiEndo initiates Phase 2a trial

November 15, 2022

EpiEndo Pharmaceuticals has received regulatory …

Affibody’s partner announces positive Phase I results

November 9, 2022

Affibody’s licensee Rallybio Corporation has …

Göran Forsberg Photo Håkan Sandbring

Cantargia reports new promising data

November 8, 2022

Cantargia has reported new data …

Patric Stenberg

Gesynta Pharma prepares Phase II study of GS-248 in endometriosis

November 1, 2022

Gesynta Pharma has announced the …

Ultimovacs lab

First patient randomized in Ultimovacs’ LUNGVAC trial

October 26, 2022

Ultimovacs has announced that the …

Martin Olin

BerGenBio initiates Phase 1b/2a trial

October 14, 2022

BerGenBio has announced the initiation …

Nykode announces positive Phase 1/2 results

October 14, 2022

Nykode Therapeutics has announced clinical …

First US patient dosed in TILT’s Phase I study

October 11, 2022

TILT Biotherapeutics has announced that …

Orexo announces positive Phase I data

October 11, 2022

Orexo has announced positive results …

1
2
3
···
45